| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.002 | 1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |